Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sanuwave Health Inc (SNWV)

Sanuwave Health Inc (SNWV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sanuwave Health Inc 11495 Valley View Road Eden Prairie MN 55344 USA

www.sanuwave.com Employees: 31 P: 952-656-1029

Description:

SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.

Key Statistics

Overview:

Market Capitalization, $K 33,430
Enterprise Value, $K 54,480
Shares Outstanding, K 1,181,273
Annual Sales, $ 20,400 K
Annual Net Income, $ -25,810 K
Last Quarter Sales, $ 7,160 K
Last Quarter Net Income, $ 6,560 K
EBIT, $ 2,190 K
EBITDA, $ 10,130 K
60-Month Beta 1.15
% of Insider Shareholders 16.40%
% of Institutional Shareholders 42.53%
Float, K 987,544
% Float 83.60%
Short Volume Ratio 0.77

Growth:

1-Year Return 66.67%
3-Year Return -76.42%
5-Year Return -80.47%
5-Year Revenue Growth 1,002.70%
5-Year Earnings Growth 62.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 08/12/24
Next Earnings Date 11/14/24
Earnings Per Share ttm 0.03
EPS Growth vs. Prev Year 200.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SNWV Ratios

Ratio
Price/Earnings ttm 0.93
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -23.83%
Return-on-Assets % 53.73%
Profit Margin % -126.52%
Debt/Equity -0.60
Price/Sales 1.62
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.03
Interest Coverage -0.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar